Are membership plans a win-win for consumers and private healthcare providers? We use data from Rare.Monitor to address the question.
6,193 private healthcare providers in the UK now offer some form of membership, loyalty, or payment plan, according to Rare.Monitor data. That represents 11.5% of the UK private healthcare market. The category has grown substantially as NHS access pressure has pushed patients into private provision and as providers have looked for ways to lock in patient lifetime value rather than rely on episodic visits.
The breakdown
Payment plans: 5,766 providers
Loyalty schemes: 455 providers
Membership schemes: 371 providers
The distribution is informative. Payment plans are by far the most common, while genuine membership schemes remain a small share of the market. The question for the next phase of the market is whether membership schemes follow the same growth trajectory that loyalty and subscription models have followed in other consumer categories.
The three models, what they actually do
These categories are often used interchangeably. They are not the same thing.
Loyalty schemes. Points or discounts earned for repeat custom. Familiar from retail and airlines. Encourages return visits but does not change access to care or guarantee anything to the patient upfront.
Payment plans. Spread treatment cost over time. Helps with affordability but does not change the underlying transaction. Patients still pay per treatment, just in instalments.
Membership schemes. A subscription paid monthly or annually for access to defined services, often including priority booking, discounted consultations, or unlimited GP access. Different commercial logic from the other two: the patient buys an ongoing relationship, not a discount on individual transactions.
Why membership has the strongest long-term logic
Payment plans are useful but commoditised. Loyalty schemes work for repeat consumers but offer little to first-time patients. Membership schemes do something the other two cannot: they convert episodic care into a continuous relationship with predictable costs on both sides.
The benefits to the patient include guaranteed appointment availability, fixed and predictable cost, and a shift from reactive treatment to proactive health management. The benefits to the provider include a more stable monthly revenue line, better patient engagement, and a structural reason for patients not to shop around on individual treatments.
The catch is design. Membership schemes only deliver if the benefits are meaningful and the cost reflects fair value. Schemes that are membership in name only, with little perceptible benefit over paying per treatment, will not retain members. Providers thinking about membership need to design the value proposition before the pricing.
Where the market goes from here
Private healthcare in the UK has a real opportunity to rebuild the patient relationship around membership rather than transaction. Payment plans are useful but they are not transformational. Membership schemes, designed well, change the economics for both patient and provider.
The open question is whether providers prioritise genuine patient value or treat membership as a soft revenue mechanism. The answer, played out across thousands of providers, will determine whether private healthcare in the UK becomes more or less accessible over the next decade.
